Nature Communications (Mar 2019)

Assessing the causal association of glycine with risk of cardio-metabolic diseases

  • Laura B. L. Wittemans,
  • Luca A. Lotta,
  • Clare Oliver-Williams,
  • Isobel D. Stewart,
  • Praveen Surendran,
  • Savita Karthikeyan,
  • Felix R. Day,
  • Albert Koulman,
  • Fumiaki Imamura,
  • Lingyao Zeng,
  • Jeanette Erdmann,
  • Heribert Schunkert,
  • Kay-Tee Khaw,
  • Julian L. Griffin,
  • Nita G. Forouhi,
  • Robert A. Scott,
  • Angela M. Wood,
  • Stephen Burgess,
  • Joanna M. M. Howson,
  • John Danesh,
  • Nicholas J. Wareham,
  • Adam S. Butterworth,
  • Claudia Langenberg

DOI
https://doi.org/10.1038/s41467-019-08936-1
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 13

Abstract

Read online

Epidemiological studies have associated circulating levels of the amino acid glycine with cardiometabolic outcomes. Here, in a genome-wide meta-analysis of 80,003 individuals, Wittemans et al. identify 22 novel genetic loci for glycine and find a causal relationship with coronary heart disease using MR.